BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 5067879)

  • 1. [Missed gout].
    Rückert KH; Chowanetz W
    Munch Med Wochenschr; 1972 Apr; 114(14):663-5. PubMed ID: 5067879
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prognosis and prevention of gout complications].
    Lavicka J
    Beitr Rheumatol; 1972; 18():86-8. PubMed ID: 4649125
    [No Abstract]   [Full Text] [Related]  

  • 3. Hyperuricemia and gout. Classification, complications and management.
    Boss GR; Seegmiller JE
    N Engl J Med; 1979 Jun; 300(26):1459-68. PubMed ID: 221806
    [No Abstract]   [Full Text] [Related]  

  • 4. Pathogenesis and clinical management of hyperuricemia and gout.
    Mangini RJ
    J Maine Med Assoc; 1979 Mar; 70(3):118-20, 122-7. PubMed ID: 374661
    [No Abstract]   [Full Text] [Related]  

  • 5. [Long-term therapy of gout and hyperuricemia].
    Heidelmann G
    Z Gesamte Inn Med; 1973 Mar; 28(5):76-80. PubMed ID: 4705902
    [No Abstract]   [Full Text] [Related]  

  • 6. [Advances in the treatment of gout and hyperuricemia].
    Rapado A
    Rev Clin Esp; 1981 May; 161(4):269-73. PubMed ID: 7280337
    [No Abstract]   [Full Text] [Related]  

  • 7. Diagnostic and therapeutic aids in gout and hyperuricemia.
    Bollet AJ
    Med Times; 1981 Aug; 109(8):23-31. PubMed ID: 7278540
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug therapy reviews: pathogenesis and clinical management of hyperuricemia and gout.
    Mangini RJ
    Am J Hosp Pharm; 1979 Apr; 36(4):497-504. PubMed ID: 433935
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hyperuricemia and gout--treatment].
    Gröbner W; Walter-Sack I
    Dtsch Med Wochenschr; 2002 Feb; 127(5):210-3. PubMed ID: 11821994
    [No Abstract]   [Full Text] [Related]  

  • 10. [Uninterrupted therapy of hyperuricemia and gout].
    Schilling F
    Reumatizam; 1971; 18(3):79-82. PubMed ID: 5097291
    [No Abstract]   [Full Text] [Related]  

  • 11. [Features differentiating between gout and asymptomatic hyperuricemias (1). Clinical study].
    Bueno Jiménez C; Gil Micharet MS; Grau Linares V; Pérez Miranda M
    Rev Clin Esp; 1983 Sep; 170(5):199-203. PubMed ID: 6647941
    [No Abstract]   [Full Text] [Related]  

  • 12. [Kidney involvement in gout].
    Stein G
    Beitr Rheumatol; 1972; 18():61-7. PubMed ID: 4649120
    [No Abstract]   [Full Text] [Related]  

  • 13. [Diagnosis and therapy of gout and hyperuricemia].
    Guzmán L
    Rev Med Chil; 1981 Dec; 109(12):1191-7. PubMed ID: 7346920
    [No Abstract]   [Full Text] [Related]  

  • 14. The diagnosis and management of gouty arthritis.
    Edwards NL
    Compr Ther; 1983 Sep; 9(9):14-9. PubMed ID: 6627900
    [No Abstract]   [Full Text] [Related]  

  • 15. [Gout. Clinical aspects, pathogenesis, current treatment].
    Galmiche P
    Cah Med; 1971 Apr; 12(6):403-13. PubMed ID: 4934051
    [No Abstract]   [Full Text] [Related]  

  • 16. [Inhibition of endogenous synthesis of uric acid with allopurinol in patients with gout and urate diathesis].
    Holländer E; Schwarczmann P
    Munch Med Wochenschr; 1969 Aug; 111(32):1623-6. PubMed ID: 5394966
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hyperuricemia due to hypoxanthine-guanine-phosphoribosyltransferase deficiency].
    Blétry O; Cartier P; Hamet M; Clauvel JP
    Nouv Presse Med; 1974 Apr; 3(16):995-9. PubMed ID: 4836472
    [No Abstract]   [Full Text] [Related]  

  • 18. [Gouty nephropathy (a review of the literature)].
    Siniachenko OV; Diadyk AI; Vasilenko IV
    Vrach Delo; 1984 Jul; (7):96-100. PubMed ID: 6475032
    [No Abstract]   [Full Text] [Related]  

  • 19. Diagnosis of gout.
    Talbott JH
    Clin Orthop Relat Res; 1970; 71():23-7. PubMed ID: 5433386
    [No Abstract]   [Full Text] [Related]  

  • 20. [Gout].
    Radi I
    Schweiz Med Wochenschr; 1970 Feb; 100(8):383-6. PubMed ID: 4946973
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.